Fampridine in multiple sclerosis patients with acute phase of cervical transverse myelitis: a double-blind, randomized placebo-controlled trial.

Siavash Shirzadeh BaroughHossein PakdamanFaezeh KaramianiFaezeh MohammadiSiavash Shirzadeh BaroughFatemeh SiavoshiSaba IlkhaniMohammadali Sahraian

Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2022)

Using fampridine plus IVMP in the acute phase of transverse myelitis in MS patients improved the disease's symptoms and increased the daily activity ability of patients.

Keyphrases

multiple sclerosis
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
randomized controlled trial
mass spectrometry
open label
ms ms
patient reported outcomes
study protocol
phase iii
phase ii